PL2381784T3 - Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni - Google Patents

Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni

Info

Publication number
PL2381784T3
PL2381784T3 PL09832494T PL09832494T PL2381784T3 PL 2381784 T3 PL2381784 T3 PL 2381784T3 PL 09832494 T PL09832494 T PL 09832494T PL 09832494 T PL09832494 T PL 09832494T PL 2381784 T3 PL2381784 T3 PL 2381784T3
Authority
PL
Poland
Prior art keywords
strength
nutritional intervention
muscular function
improving muscular
improving
Prior art date
Application number
PL09832494T
Other languages
English (en)
Inventor
John Rathmacher
John Fuller
Shawn Baier
Steven Nissen
Naji Abumrad
Original Assignee
Metabolic Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolic Technologies, Inc. filed Critical Metabolic Technologies, Inc.
Publication of PL2381784T3 publication Critical patent/PL2381784T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09832494T 2008-12-09 2009-12-09 Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni PL2381784T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12106508P 2008-12-09 2008-12-09
EP09832494.0A EP2381784B1 (en) 2008-12-09 2009-12-09 Nutritional intervention for improving muscular function and strength
PCT/US2009/067382 WO2010068696A1 (en) 2008-12-09 2009-12-09 Nutritional intervention for improving muscular function and strength

Publications (1)

Publication Number Publication Date
PL2381784T3 true PL2381784T3 (pl) 2019-01-31

Family

ID=42243059

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09832494T PL2381784T3 (pl) 2008-12-09 2009-12-09 Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni

Country Status (9)

Country Link
US (1) US8815280B2 (pl)
EP (2) EP3403516A1 (pl)
CA (1) CA2746420C (pl)
DK (1) DK2381784T3 (pl)
ES (1) ES2689700T3 (pl)
HU (1) HUE039841T2 (pl)
PL (1) PL2381784T3 (pl)
PT (1) PT2381784T (pl)
WO (1) WO2010068696A1 (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
ES2548432T3 (es) * 2005-12-19 2015-10-16 Abbott Laboratories Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2
US9707241B2 (en) * 2008-12-09 2017-07-18 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US11173167B2 (en) * 2008-12-09 2021-11-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9539224B2 (en) * 2008-12-09 2017-01-10 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9259430B2 (en) * 2008-12-09 2016-02-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9770424B2 (en) * 2008-12-09 2017-09-26 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
ES2608483T3 (es) * 2009-12-18 2017-04-11 Metabolic Technologies, Inc. Método mejorado de administración de beta-hidroxi-beta-metilbutirato (HMB)
SG182812A1 (en) 2010-01-29 2012-09-27 Abbott Lab Nutritional emulsions comprising calcium hmb
WO2011094548A1 (en) 2010-01-29 2011-08-04 Abbott Laboratories Aseptically packaged nutritional liquids comprising hmb
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
TWI526161B (zh) * 2010-06-10 2016-03-21 亞培公司 包含鈣hmb及可溶性蛋白質之實質上透明營養液
EP2658535A1 (en) * 2010-12-27 2013-11-06 Abbott Laboratories Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
WO2012097061A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism
US9326956B2 (en) 2011-02-17 2016-05-03 Abbott Laboratories Methods for improving brain development and cognitive function using beta-hydroxy-beta methylbutyrate
US9327001B2 (en) 2011-11-03 2016-05-03 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
US20140156297A1 (en) * 2012-08-03 2014-06-05 Axelacare Holdings, Inc. Computer program, method, and system for pharmacist-assisted treatment of patients
US20140039907A1 (en) * 2012-08-03 2014-02-06 AxelaCare Health Solutions, Inc. Computer program, method, and system for collecting patient data with a portable electronic device
BR112015005199B1 (pt) * 2012-09-10 2022-09-06 Metabolic Technologies, Inc Composição, e, método para fornecer um benefício a um animal em necessidade do mesmo
MX2015003498A (es) * 2012-09-17 2015-06-04 Abbott Lab Composiciones que contienen acido beta-hidroxi-beta-metilbutirico y usos de las mismas.
MX367861B (es) * 2012-10-04 2019-09-09 Abbott Lab Una composición nutricional para usarse en la preservación del músculo esquelético.
CN106061291A (zh) * 2013-12-18 2016-10-26 雅培公司 使用绿茶提取物来增加骨骼肌蛋白质合成的方法
CN118844612A (zh) 2014-03-14 2024-10-29 代谢科技有限公司 含有游离酸形式的β-羟基-β-甲基丁酸盐(HMB)的液体和食品
WO2015148982A1 (en) 2014-03-27 2015-10-01 Winterfield Roland W Beta-hydroxy beta-methylbutyrate for alleviating statin myopathy
US20160184248A1 (en) * 2014-12-15 2016-06-30 University Of Central Florida Research Foundation Inc. Compositions and methods of use of -hydroxy-methylbutyrate (hmb) resulting in an acute endocrine response
ES2937282T3 (es) * 2015-06-01 2023-03-27 Metabolic Tech Llc Composiciones y métodos de uso del beta-hidroxi-beta-metilbutirato (HMB) para disminuir la masa grasa
US12370159B2 (en) 2016-10-21 2025-07-29 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics
JP7583523B2 (ja) * 2016-10-21 2024-11-14 メタボリック・テクノロジーズ,インコーポレーテッド β-ヒドロキシ-β-メチルブチレート(HMB)およびプロバイオティックを使用する組成物および方法
US10888576B2 (en) 2018-10-08 2021-01-12 Metabolic Technologies, Inc. Composition of HMB and ATP and methods of use
EP3947336B1 (en) 2019-04-02 2023-03-15 Evonik Operations GmbH Process for preparing 3-hydroxy-3-methylbutyrate (hmb) and salts thereof
JP2021070643A (ja) * 2019-10-30 2021-05-06 小林製薬株式会社 筋肉量改善用組成物
AU2021292308A1 (en) * 2020-06-17 2023-02-09 Metabolic Technologies, LLC Compositions and methods of use of betaeta-hydroxy-betaeta-methylbutyrate (hmb) for improving muscle mass, strength and muscular function without exercise
EP3951016A1 (en) 2020-08-05 2022-02-09 Evonik Operations GmbH Method for preparing 3-hydroxy-3-methylbutyric acid (hmb) or salts thereof
EP4284355A1 (en) * 2021-01-28 2023-12-06 Abbott Laboratories Methods and nutritional compositions for improving muscle energy production and/or strength
EP4312594A1 (en) * 2021-03-31 2024-02-07 Abbott Laboratories Methods and compositions for improving insulin production and secretion
WO2022225786A1 (en) * 2021-04-22 2022-10-27 Abbott Laboratories Methods and compositions for improving muscle strength and/or reducing muscle loss
CN117502654A (zh) * 2023-05-09 2024-02-06 内蒙古欧世蒙牛乳制品有限责任公司 一种改善肌肉及提高行动力的组合物及食品和组合物的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087472A (en) 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
US5028440A (en) 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US4992470A (en) 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals
JPH03256371A (ja) * 1990-03-06 1991-11-15 Eastman Kodak Japan Kk 発光ダイオード及びそのアレイ
JP3148243B2 (ja) * 1992-09-16 2001-03-19 アイオワ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 総コレステロールおよび低密度リポタンパク質コレステロールの血中レベルを減少させる方法
US5348979A (en) * 1992-12-23 1994-09-20 Iowa State University Research Foundation Inc. Method of promoting nitrogen retention in humans
US6103764A (en) * 1997-11-07 2000-08-15 Iowa State University Research Foundation, Inc. Method for increasing the aerobic capacity of muscle
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
US6291525B1 (en) * 1999-09-08 2001-09-18 Iowa State University Research Foundation, Inc. Method for improving a human's perception of his emotional state
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
ES2548432T3 (es) * 2005-12-19 2015-10-16 Abbott Laboratories Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2
AU2007287070C1 (en) * 2006-08-24 2013-02-14 University Of Tennessee Research Foundation Substituted acylanilides and methods of use thereof

Also Published As

Publication number Publication date
CA2746420C (en) 2019-11-12
CA2746420A1 (en) 2010-06-17
DK2381784T3 (en) 2018-10-22
EP2381784A1 (en) 2011-11-02
PT2381784T (pt) 2018-10-30
EP2381784B1 (en) 2018-07-11
US8815280B2 (en) 2014-08-26
US20100179112A1 (en) 2010-07-15
WO2010068696A1 (en) 2010-06-17
HUE039841T2 (hu) 2019-02-28
EP3403516A1 (en) 2018-11-21
EP2381784A4 (en) 2013-10-16
ES2689700T3 (es) 2018-11-15

Similar Documents

Publication Publication Date Title
HUE039841T2 (hu) Táplálkozási beavatkozás izomfunkció és erõ növeléséhez
EP2277138A4 (en) PLACEMENT OF ARTICLES
IL210804A (en) Benzylidenehydrazides and their uses
HUE037323T2 (hu) Törlõkar-törlõlapát összekapcsolás, valamint törlõlapát
PL2315705T3 (pl) Zamknięcie z przyrządem
GB0808575D0 (en) Compilign and linking
ZA201104742B (en) Strains and methods for improving ruminant health and/or performance
GB2463514B (en) Imidazolidine compounds and uses therefor
GB0819720D0 (en) Methods and products
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
ZA201103456B (en) Leukolectins and uses thereof
GB0805279D0 (en) Food supplement
PL2247601T3 (pl) Tiazopirymidynony i ich zastosowanie
ZA201104161B (en) Dihydroetorphines and their preparation
ZA201005417B (en) Nutritious drink
ZA201108855B (en) Wellness shoe and method
GB0912744D0 (en) Methods and uses
GB0802327D0 (en) An improved tortilla press
GB0813359D0 (en) Halfin and/or platerfin
GB0809973D0 (en) Web-based content
AU4085P (en) AR584 Neotyphodium coenophialum
GB0816523D0 (en) Methods and uses
GB0810609D0 (en) Methods and uses
GB0808857D0 (en) Methdos and uses
GB0803731D0 (en) Methods and products